Order Article Reprints

Khan A, Alsahli MA, Aljasir MA, Maswadeh H, Mobark MA, Azam F, Allemailem KS, Alrumaihi F, Alhumaydhi FA, Alwashmi ASS, et al. Safety, Stability, and Therapeutic Efficacy of Long-Circulating TQ-Incorporated Liposomes: Implication in the Treatment of Lung Cancer. Pharmaceutics. 2022; 14(1):153. https://doi.org/10.3390/pharmaceutics14010153

Khan, Arif, Mohammed A. Alsahli, Mohammad A. Aljasir, Hamzah Maswadeh, Mugahid A. Mobark, Faizul Azam, Khaled S. Allemailem, Faris Alrumaihi, Fahad A. Alhumaydhi, Ameen S. S. Alwashmi, and et al. 2022. "Safety, Stability, and Therapeutic Efficacy of Long-Circulating TQ-Incorporated Liposomes: Implication in the Treatment of Lung Cancer" Pharmaceutics 14, no. 1: 153. https://doi.org/10.3390/pharmaceutics14010153

Khan, A., Alsahli, M. A., Aljasir, M. A., Maswadeh, H., Mobark, M. A., Azam, F., Allemailem, K. S., Alrumaihi, F., Alhumaydhi, F. A., Alwashmi, A. S. S., Almatroudi, A. A., Alsugoor, M. H., & Khan, M. A. (2022). Safety, Stability, and Therapeutic Efficacy of Long-Circulating TQ-Incorporated Liposomes: Implication in the Treatment of Lung Cancer. Pharmaceutics, 14(1), 153. https://doi.org/10.3390/pharmaceutics14010153